rss
Heart 2010;96:190-195 doi:10.1136/hrt.2009.180448
  • Acute coronary syndromes

Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study

  1. J D Haeck1,
  2. W J Kuijt1,4,
  3. K T Koch1,
  4. L Bilodeau2,
  5. J P Henriques1,
  6. W J Rohling1,
  7. J Baan Jr1,
  8. M M Vis1,
  9. R Nijveldt3,
  10. N van Geloven1,
  11. M Groenink1,
  12. J J Piek1,
  13. J G Tijssen1,
  14. M W Krucoff4,
  15. R J De Winter1
  1. 1Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  2. 2Department of Cardiology, Institut de Cardiology de Montréal, Montréal, Quebec, Canada
  3. 3Department of Cardiology, Vrije University Medical Center, Amsterdam, The Netherlands
  4. 4Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
  1. Correspondence to Dr J D Haeck, Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; j.d.haeck{at}amc.uva.nl
  • Accepted 5 October 2009
  • Published Online First 26 October 2009

Abstract

Objectives The aim of the study was to evaluate whether primary percutaneous coronary intervention (PCI) with combined proximal embolic protection and thrombus aspiration results in smaller final infarct size and improved left ventricular function assessed by cardiovascular magnetic resonance (CMR) in ST-segment elevation myocardial infarction (STEMI) patients compared with primary PCI alone.

Background Primary PCI with the Proxis system improves immediate microvascular flow post-procedure as measured by ST-segment resolution, which could result in better outcomes.

Methods The ancillary CMR study included 206 STEMI patients who were enrolled in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation (PREPARE) trial. CMR imaging was assessed between 4 and 6 months after the index procedure.

Results There were no significant differences in final infarct size (6.1 g/m2 vs 6.3 g/m2, p = 0.78) and left ventricular ejection fraction (50% vs 50%, p = 0.46) between both groups. Also, systolic wall thickening in the infarct area (44% vs 45%, p = 0.93) or the extent of transmural segments (8.3% of segments vs 8.3% of segments, p = 0.60) showed no significant differences. The incidence of major adverse cardiac and cerebral events at 6 months was similar in the Proxis and control group (8% vs 10%, respectively, p = 0.43).

Conclusions Primary PCI with combined proximal embolic protection and thrombus aspiration in STEMI patients did not result in significant differences in final infarct size or left ventricular function at follow-up CMR. In addition, there was no difference in the incidence of major adverse cardiac and cerebral events at 6 months.

Trial registration number ISRCTN71104460.

Footnotes

  • Funding This study is supported by grants from St Jude Medical and from the University of Amsterdam.

  • Competing interests None.

  • Ethics approval The study protocol was approved by the institutional review board of the Academic Medical Center, University of Amsterdam.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.